Clinical trial of natural alpha interferon in multiple sclerosis.
D002986:Clinical Trials as Topic; D004311:Double-Blind Method; D006801:Humans; D007273:Injections, Intramuscular; D007370:Interferon Type I / Q000009:adverse effects / Q000627:therapeutic use*; D007694:Killer Cells, Natural / Q000276:immunology; D009103:Multiple Sclerosis / Q000276:immunology / Q000628:therapy*; D009460:Neurologic Examination; D010919:Placebos; D011897:Random Allocation; D012008:Recurrence; D013601:T-Lymphocytes / Q000276:immunology
D007370:Interferon Type I; D010919:Placebos